New study tests safer pain relief for oral cancer patients
NCT ID NCT07606638
First seen May 29, 2026 · Last updated Jun 21, 2026 · Updated 6 times
Summary
This study compares two pain management strategies for adults with oral cancer who have moderate to severe pain. One group receives the opioid tramadol, while the other gets a combination of pregabalin and naproxen sodium. Over 7 days, researchers measure pain reduction, side effects, and patient satisfaction to see which approach works better and is safer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tramadol (opioid) and pregabalin plus naproxen sodium
What this could lead to
If this trial succeeds, it could show that a non-opioid combination (pregabalin + naproxen) works as well as or better than tramadol for oral cancer pain, offering a safer alternative with fewer side effects.
What could go wrong
This is a small, single-center study with only 98 participants, so results may not apply to everyone. The short 7-day treatment period doesn't show long-term effects or risks like dependence or tolerance.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.